Literature DB >> 22094065

The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells.

Astrid V Fahlenkamp1, Rolf Rossaint, Hajo Haase, Hussam Al Kassam, Yu-Mi Ryang, Cordian Beyer, Mark Coburn.   

Abstract

Recently, the noble gas argon has been identified as a potent neuroprotective agent, but little is known about its cellular effects. In this in vitro study, we investigated argon's influence on the extracellular signal-regulated kinase (ERK) 1/2, a ubiquitous enzyme with numerous functions in cell proliferation and survival. Primary neuronal and astroglial cell cultures and the microglial cell line BV-2 were exposed to 50 vol.% argon. Further possible effects were studied following stimulation of microglia with 50 ng/ml LPS. ERK 1/2 activation was assessed by phosphorylation state-specific western blotting, cytokine levels by real-time PCR and western blotting. Total phosphotyrosine phosphatase activity was examined with p-nitrophenylphosphate. After 30 min exposure, argon significantly activated ERK 1/2 signaling in microglia. Enhanced phosphorylation of ERK 1/2 was also found in astrocytes and neurons following argon exposure, but it lacked statistical significance. In microglia, argon did not substantially interfere with LPS-induced ERK1/2 activation and inflammatory cytokine induction. Addition of the MEK-Inhibitor U0126 abolished the induced ERK 1/2 phosphorylation. Cellular phosphatase activity and the inactivation of phosphorylated ERK 1/2 were not altered by argon. In conclusion, argon enhanced ERK 1/2 activity in microglia via the upstream kinase MEK, probably through a direct mode of activation. ERK 1/2 signaling in astrocytes and neurons in vitro was also influenced, although not with statistical significance. Whether ERK 1/2 activation by argon affects cellular functions like differentiation and survival in the brain in vivo will have to be determined in future experiments.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22094065     DOI: 10.1016/j.ejphar.2011.10.045

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  34 in total

Review 1.  [Neuroprotection by noble gases: New developments and insights].

Authors:  A V Fahlenkamp; R Rossaint; M Coburn
Journal:  Anaesthesist       Date:  2015-11       Impact factor: 1.041

Review 2.  Noble gases as cardioprotectants - translatability and mechanism.

Authors:  Kirsten F Smit; Nina C Weber; Markus W Hollmann; Benedikt Preckel
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 3.  [Cardioprotection in cardiac surgical patients : Everything good comes from the heart].

Authors:  C Stoppe; P Meybohm; M Coburn; A Goetzenich
Journal:  Anaesthesist       Date:  2016-03       Impact factor: 1.041

4.  Argon Inhalation for 24 Hours After Onset of Permanent Focal Cerebral Ischemia in Rats Provides Neuroprotection and Improves Neurologic Outcome.

Authors:  Shuang Ma; Dongmei Chu; Litao Li; Jennifer A Creed; Yu-Mi Ryang; Huaxin Sheng; Wei Yang; David S Warner; Dennis A Turner; Ulrike Hoffmann
Journal:  Crit Care Med       Date:  2019-08       Impact factor: 7.598

5.  Argon Inhalation for 24 h After Closed-Head Injury Does not Improve Recovery, Neuroinflammation, or Neurologic Outcome in Mice.

Authors:  Jennifer Creed; Viviana Cantillana-Riquelme; Bai Hui Yan; Shuang Ma; Dongmei Chu; Haichen Wang; Dennis A Turner; Daniel T Laskowitz; Ulrike Hoffmann
Journal:  Neurocrit Care       Date:  2020-09-21       Impact factor: 3.210

6.  Delayed argon administration provides robust protection against cardiac arrest-induced neurological damage.

Authors:  Anne Brücken; Pinar Kurnaz; Christian Bleilevens; Matthias Derwall; Joachim Weis; Kay Nolte; Rolf Rossaint; Michael Fries
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

7.  Pharmacokinetic analysis of the chronic administration of the inert gases Xe and Ar using a physiological based model.

Authors:  Ira Katz; Jacqueline Murdock; Marc Palgen; Jan Pype; Georges Caillibotte
Journal:  Med Gas Res       Date:  2015-05-29

8.  Argon: a novel therapeutic option to treat neuronal ischemia and reperfusion injuries?

Authors:  Felix Ulbrich; Ulrich Goebel
Journal:  Neural Regen Res       Date:  2015-07       Impact factor: 5.135

9.  Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4.

Authors:  Felix Ulbrich; Kai Kaufmann; Martin Roesslein; Franziska Wellner; Volker Auwärter; Jürgen Kempf; Torsten Loop; Hartmut Buerkle; Ulrich Goebel
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

10.  Argon gas: a potential neuroprotectant and promising medical therapy.

Authors:  Derek S Nowrangi; Jiping Tang; John H Zhang
Journal:  Med Gas Res       Date:  2014-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.